[Latest] Global Ultomiris Drug Market Size/Share Worth USD 64.12 Billion by 2034 at a 31.52% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Ultomiris Drug Market size & share revenue was valued at approximately USD 4.16 Billion in 2024 and is expected to reach USD 5.47 Billion in 2025 and is expected to reach around USD 64.12 Billion by 2034, at a CAGR of 31.52% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are AstraZeneca, Xencor, Inc., Chugai Pharmaceutical, Argenx, Alexion Pharmaceuticals , and others.

Austin, TX, USA, July 16, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Ultomiris Drug Market Size, Trends and Insights By Indication (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), Neuromyelitis Optica Spectrum Disorder (NMOSD)), By End-use (Adult, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034” in its research database.

“According to the latest research study, the demand of the global Ultomiris Drug Market size & share was valued at approximately USD 4.16 Billion in 2024 and is expected to reach USD 5.47 Billion in 2025 and is expected to reach a value of around USD 64.12 Billion by 2034, at a compound annual growth rate (CAGR) of about 31.52% during the forecast period 2025 to 2034.”

Click Here to Access a Free Sample Report of the Global Ultomiris Drug Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=70951

Overview

As per the industry experts at CMI, the global ultomiris drug market will witness a whopping CAGR between 2025 and 2034. This could be attributed to the rise in demand for various long-acting treatments for rare disorders, especially paroxysmal nocturnal hemoglobinuria (PNH) and generalized myasthenia gravis (gMG). North America holds the largest market share due to speedy adoption of ultomiris drug by the U.S. and Canada. Hospital pharmacies dominate as far as distribution channels are concerned.

Key Trends & Drivers

• Long-Acting Treatment Preference to Spell Growth: Ultomiris does offer a long-acting dosing interval (every 8 weeks), which enhances patient convenience and compliance as compared to the shorter-acting alternatives. Ultomiris is also known for demonstrating robust clinical performance along with a well-established safety profile.

Request a Customized Copy of the Ultomiris Drug Market Report @ https://www.custommarketinsights.com/request-for-customization/?reportid=70951

• Approval by Regulatory Bodies to Catalyze Growth: The U.S. FDA had approved ultomiris for adults suffering from gMG in the year 2022. Since then, the drug has strengthened its position in the neurology sector. The FDA also conducted a review on priority in March 2024 for ultomiris in NMOSD. These approvals and reviews are bound to take the ultomiris market to the next level in the forecast period.

Report Scope

Feature of the Report	Details
Market Size in 2025	USD 5.47 Billion
Projected Market Size in 2034	USD 64.12 Billion
Market Size in 2024	USD 4.16 Billion
CAGR Growth Rate	31.52% CAGR
Base Year	2024
Forecast Period	2025-2034
Prominent Players	AstraZeneca, Xencor Inc., Chugai Pharmaceutical, Argenx, Alexion Pharmaceuticals , Others, and Others
Key Segment	By Indication, End-use, Distribution Channel and Region
Report Coverage	Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope	North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options	Request tailored purchasing options to fulfil your requirements for research.

(A free sample of the Ultomiris Drug report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the following:

• Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report.
• The COVID-19 Pandemic Outbreak Impact Analysis is included in the package.
• About 220+ Pages Research Report (Including Recent Research)
• Provide detailed chapter-by-chapter guidance on the Request.
• Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025
• Includes Tables and figures have been updated.
• The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis 
• Custom Market Insights (CMI) research methodology

(Please note that the sample of the Ultomiris Drug report has been modified to include the COVID-19 impact study prior to delivery.)

Request a Customized Copy of the Ultomiris Drug Market Report @ https://www.custommarketinsights.com/report/ultomiris-drug-market/

SWOT Analysis

• Strengths: Ultomiris has demonstrated a manageable safety profile and efficacy in the treatment of gMG and PNH. With the market for rare disease therapies growing on the whole, a favorable environment is created for ultomiris. Also, ongoing research coupled with clinical trials is bound to result in extra approved indications for ultomiris drug, thereby bolstering its market potential.

• Weaknesses: Ultomiris is quite expensive. This is likely to apply brakes to its accessibility for certain patients, particularly in the resource-limited settings. Moreover, the need for intravenous infusion could be a barrier to patient convenience and preference.

• Opportunities: Ultomiris has a huge potential for growth in the emerging markets with expansion of healthcare infrastructure and awareness regarding rare diseases. Furthermore, a subcutaneous formulation on the part of ultomiris is likely to offer a convenient route of administration for the patients. Also, exploration of the potential of combining ultomiris with the other therapies for improving treatment outcomes could fetch more revenue.

• Threats: There are pharmaceutical companies developing competing therapies for gMG and PNH, which is likely to erode the market share of ultomiris. Also, the development as well as the approval of ultomiris’ biosimilar version is likely to adversely affect the market pricing and share.

Request a Customized Copy of the Ultomiris Drug Market Report @ https://www.custommarketinsights.com/report/ultomiris-drug-market/

Key questions answered in this report:

• What is the size of the Ultomiris Drug market and what is its expected growth rate?
• What are the primary driving factors that push the Ultomiris Drug market forward?
• What are the Ultomiris Drug Industry's top companies?
• What are the different categories that the Ultomiris Drug Market caters to?
• What will be the fastest-growing segment or region?
• In the value chain, what role do essential players play?
• What is the procedure for getting a free copy of the Ultomiris Drug market sample report and company profiles?

Key Offerings:

• Market Share, Size & Forecast by Revenue | 2025−2034
• Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends
• Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions
• Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Buy this Premium Ultomiris Drug Research Report | Fast Delivery Available - [220+ Pages] @ https://www.custommarketinsights.com/report/ultomiris-drug-market/

Regional Perspective

The ultomiris drug market is classified into North America, Europe, Asia Pacific, and LAMEA.

• North America

North America accounts for more than 40% of the market share, and the status quo is expected to remain unchanged during the forecast period. This could be credited to the U.S. being equipped with advanced diagnostic capabilities, which enable early detection as well as treatment of aHUS and PNH.

Switching to ultomiris from soliris is witnessing acceleration, which is supported by the former’s dosing intervals. Speedy adoption of innovative therapies and strong clinical trial activity are bolstering the market further. Higher level of awareness amongst the healthcare professionals regarding rare diseases ascertains timely intervention and diagnosis. Preference for therapies with a reduction in treatment burden does favor ultomiris over its counterparts.

• Asia Pacific

The Asia Pacific is expected to expand at the fastest CAGR in the ultomiris market due to the rise in the number of patients with rare diseases. Improvement in healthcare infrastructure does improve access to advanced treatments through diagnosis.

The structured approach toward rare disease management in Japan extends support to patient identification as well as treatment initiation. Integrating ultomiris into clinical practice does reflect the perceived benefits. Such elements do contribute to the presence of this drug in Japan.

China’s expanding healthcare system and emphasis on rare diseases do contribute to the growth of ultomiris market. Efforts in the direction of improving diagnostic capabilities facilitate detection of aHUS and PNH earlier. Moreover, increasing familiarity of healthcare professionals with complement inhibitors lends support to the adoption of the drug.

• Europe

Europe’s ultomiris market is strongly supported by growing awareness as well as diagnosis regarding rare diseases. Of late, ultomiris has been approved for pediatric use regarding conditions such as PNH. Clinical recommendations and guidelines do endorse the usage of ultomiris in the patient population. This transition to ultomiris from the existing therapies does reflect the perceived benefits. The region’s emphasis on improvement of patient quality of life does support adopting treatments needing lesser hospital visits.

• LAMEA

In LAMEA, physicians are increasingly recommending longer-acting treatment for reducing clinical visits and improving patient compliance. The educational efforts are improving understanding of complement-mediated cases across all the markets. Though regulatory timelines could vary, frequency of approvals is expanding across various countries. partnerships and collaborations in the healthcare sector contribute to the development of the market.

Request a Customized Copy of the Ultomiris Drug Market Report @  https://www.custommarketinsights.com/report/ultomiris-drug-market/

(We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.)

Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? 

Email Directly Here with Detail Information: support@custommarketinsights.com

Browse the full “Ultomiris Drug Market Size, Trends and Insights By Indication (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), Neuromyelitis Optica Spectrum Disorder (NMOSD)), By End-use (Adult, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034” Report at https://www.custommarketinsights.com/report/ultomiris-drug-market/

List of the prominent players in the Ultomiris Drug Market:

• AstraZeneca
• Xencor Inc.
• Chugai Pharmaceutical
• Argenx
• Alexion Pharmaceuticals
• Others

Click Here to Access a Free Sample Report of the Global Ultomiris Drug Market @  https://www.custommarketinsights.com/report/ultomiris-drug-market/

Spectacular Deals

• Comprehensive coverage
• Maximum number of market tables and figures
• The subscription-based option is offered.
• Best price guarantee
• Free 35% or 60 hours of customization.
• Free post-sale service assistance.
• 25% discount on your next purchase.
• Service guarantees are available.
• Personalized market brief by author.

Browse More Related Reports: 

Pet Oral Care Products Market: Pet Oral Care Products Market Size, Trends and Insights By Product Type (Toothbrush, Toothpaste, Mouthwash/Rinse, Dental Chews, Others), By Animal Type (Dogs, Cats, Others), By Application (Residential, Commercial), By Distribution Channel (Supermarkets and Hypermarkets, Online Stores, Specialized Pet Shops, Veterinary Channels), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034

Magnesium Supplements Market: Magnesium Supplements Market Size, Trends and Insights By Type (Tablets, Capsules, Powders, Liquids), By Application (Dietary Supplements, Pharmaceuticals, Animal Feed, Others), By Distribution Channel (Online, Offline), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034

Blockchain-Based Electronic Health Record Market: Blockchain-Based Electronic Health Record Market Size, Trends and Insights By Blockchain Type (Public Blockchain, Private Blockchain, Consortium/Permissioned Blockchain, Hybrid Blockchain), By Application (Patient Record Management, Clinical Trial Data Sharing, E-prescription & Medical Billing, Medical Imaging & Diagnostics, Insurance Claim & Fraud Detection, Remote Patient Monitoring (via IoMT)), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034

AI in Synthetic Biology Market: AI in Synthetic Biology Market Size, Trends and Insights By Technology (Gene Synthesis, Genome Editing, Synthetic Biology Tools, Bioinformatics), By Application (Healthcare & Medicine, Agricultural Biotechnology, Industrial Biotechnology, Environmental Biotechnology), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034

Advanced Genomics Market: Advanced Genomics Market Size, Trends and Insights By Offering (Products, Services), By Technology (Sequencing, PCR, Gene Editing, Flow Cytometry, Microarrays, In Situ Hybridization), By Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture), By End-user (Hospitals and Clinics, Research Centers, Pharmaceutical and Biotechnology Companies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034

Cell and Gene Therapy Market: Cell and Gene Therapy Market Size, Trends and Insights By Therapy Type (Cell Theray, Gene Therapy), By Therapeutic Class (Cardiovascular Disease, Cancer, Genetic Disorder, Rare Diseases, Oncology, Hematology, Ophthalmology, Infectious Disease, Neurological Disorders, Others), By Delivery Method (In Vivo, Ex Vivo), By End-User (Hospitals, Cancer Care Centers, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034

Battery-Free Implants Market: Battery-Free Implants Market Size, Trends and Insights By Product Type (Neural Implants, Cardiac Implants , Cochlear Implants, Orthopedic Implants, Others), By Technology (Energy Harvesting, Wireless Power Transfer, RFID/NFC-based Systems), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutions, Specialty Clinics), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034

Alzheimer’s Drug Market: Alzheimer’s Drug Market Size, Trends and Insights By Type of Drug (Disease-Modifying Therapies (DMTs), Symptomatic Therapies), By Application (Amyloid-Targeting Agents, Tau-Targeting Agents, Cholinesterase Inhibitors, NMDA Antagonists, Other Agents), By End User (Hospitals, Clinics, Home Care Settings), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034

The Ultomiris Drug Market is segmented as follows:

By Indication

• Paroxysmal Nocturnal Hemoglobinuria (PNH)
• Atypical Hemolytic Uremic Syndrome (aHUS)
• Generalized Myasthenia Gravis (gMG)
• Neuromyelitis Optica Spectrum Disorder (NMOSD)

By End-use

• Adult
• Pediatric

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Click Here to Get a Free Sample Report of the Global Ultomiris Drug Market @ https://www.custommarketinsights.com/report/ultomiris-drug-market/

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America

This Ultomiris Drug Market Research/Analysis Report Contains Answers to the following Questions.

• Which Trends Are Causing These Developments?
• Who Are the Global Key Players in This Ultomiris Drug Market? What are Their Company Profile, Product Information, and Contact Information?
• What Was the Global Market Status of the Ultomiris Drug Market? What Was the Capacity, Production Value, Cost and PROFIT of the Ultomiris Drug Market?
• What Is the Current Market Status of the Ultomiris Drug Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of Ultomiris Drug Market by Considering Applications and Types?
• What Are Projections of the Global Ultomiris Drug Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports?
• What Is Ultomiris Drug Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
• What Is the Economic Impact On Ultomiris Drug Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
• What Are Market Dynamics of Ultomiris Drug Market? What Are Challenges and Opportunities?
• What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Ultomiris Drug Industry?

Click Here to Access a Free Sample Report of the Global Ultomiris Drug Market @  https://www.custommarketinsights.com/report/ultomiris-drug-market/

Reasons to Purchase Ultomiris Drug Market Report

• Ultomiris Drug Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors.
• Ultomiris Drug Market report outlines market value (USD) data for each segment and sub-segment.
• This report indicates the region and segment expected to witness the fastest growth and dominate the market.
• Ultomiris Drug Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region.
• The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled.
• Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players.
• The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions.
• Ultomiris Drug Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain.

Reasons for the Research Report

• The study provides a thorough overview of the global Ultomiris Drug market. Compare your performance to that of the market as a whole.

• Aim to maintain competitiveness while innovations from established key players fuel market growth.

Buy this Premium Ultomiris Drug Research Report | Fast Delivery Available - [220+ Pages] @  https://www.custommarketinsights.com/report/ultomiris-drug-market/

What does the report include?

• Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Ultomiris Drug market analysis.

• The competitive environment of current and potential participants in the Ultomiris Drug market is covered in the report, as well as those companies' strategic product development ambitions.

• According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions.

• For each segment mentioned above, actual market sizes and forecasts have been given.

Who should buy this report?

• Participants and stakeholders worldwide Ultomiris Drug market should find this report useful. The research will be useful to all market participants in the Ultomiris Drug industry.

• Managers in the Ultomiris Drug sector are interested in publishing up-to-date and projected data about the worldwide Ultomiris Drug market.

• Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Ultomiris Drug products' market trends.

• Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. 

Request a Customized Copy of the Ultomiris Drug Market Report @  https://www.custommarketinsights.com/report/ultomiris-drug-market/

About Custom Market Insights:

Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.

CMI offers a comprehensive solution that covers everything from data collection to investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics. The professional experts utilize client insights to inform strategies for estimating future declines, forecasting opportunities for growth, and conducting consumer surveys.

Follow Us: LinkedIn | Twitter | Facebook | YouTube

Contact Us:

Joel John

CMI Consulting LLC

1333, 701 Tillery Street Unit 12,

Austin, TX, Travis, US, 78702

USA: +1 737-734-2707

India: +91 20 46022736

Email: support@custommarketinsights.com

Web: https://www.custommarketinsights.com/

Blog: https://www.techyounme.com/

Blog: https://businessresearchindustry.com

Blog: https://www.technowalla.com/

Blog: https://marketresearchtrade.com/

Buy this Premium Ultomiris Drug Research Report | Fast Delivery Available - [220+ Pages] @ https://www.custommarketinsights.com/report/ultomiris-drug-market/